A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1.

Burgstaller, S; Stauder, R; Kuehr, T; Lang, A; Machherndl-Spandl, S; Mayrbaeurl, B; Noesslinger, T; Petzer, A; Valent, P; Greil, R; Thaler, J; Leuk Lymphoma. 2018; 59(5):1121-1126

Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

Falantes, J; Pleyer, L; Thépot, S; Almeida, AM; Maurillo, L; Martínez-Robles, V; Stauder, R; Itzykson, R; Pinto, R; Venditti, A; Bargay, J; Burgstaller, S; Martínez, MP; Seegers, V; Cortesão, E; Foncillas, MÁ; Gardin, C; Montesinos, P; Musto, P; Fenaux, P; Greil, R; Sanz, MA; Ramos, F; Leuk Lymphoma. 2018; 59(5):1113-1120

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Gassner, FJ; Schubert, M; Rebhandl, S; Spandl, K; Zaborsky, N; Catakovic, K; Blaimer, S; Hebenstreit, D; Greil, R; Geisberger, R; Mol Cancer Res. 2018; 16(3):428-438

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis.

Rinnerthaler, G; Gampenrieder, SP; Greil, R MEMO-MAG EUR MED ONC. 2018; 11(3): 208-212.

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.

Ball, B; Komrokji, RS; Ades, L; Sekeres, MA; DeZern, AE; Pleyer, L; Vey, N; Almeida, A; Germing, U; Cluzeau, T; Platzbecker, U; Gore, SD; Fenaux, P; Prebet, T BLOOD ADV. 2018; 2(16): 2063-2071.

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer

Gampenrieder, SP; Rinnerthaler, G; Hackl, H; Pulverer, W; Weinhaeusel, A; Ilic, S; Hufnagl, C; Hauser-Kronberger, C; Egle, A; Risch, A; Greil, R THERANOSTICS. 2018; 8(8): 2278-2288.

RNA Trans-Splicing Modulation via Antisense Molecule Interference.

Liemberger, B; Piñón Hofbauer, J; Wally, V; Arzt, C; Hainzl, S; Kocher, T; Murauer, EM; Bauer, JW; Reichelt, J; Koller, U; Int J Mol Sci. 2018; 19(3):

ASCO 2018 highlights: metastatic breast cancer

Rinnerthaler, G; Gampenrieder, SP; Greil, R MEMO-MAG EUR MED ONC. 2018; 11(4): 276-279.

Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.

Bachmayer, S; Fastner, G; Vaszi, A; Iglseder, W; Kopp, P; Holzinger, J; Dinnewitzer, A; Rinnerthaler, G; Gampenrieder, SP; Emmanuel, K; Greil, R; Sedlmayer, F; Zehentmayr, F; Strahlenther Onkol. 2018; 194(7): 627-637.

PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG

Eich, HT; Baues, C; Fuchs, M; Kobe, C; Greil, R; Sasse, S; Zijlstra, JM; Lohri, A; Rosenwald, A; Tresckow, BV; Diehl, V; Kuhnert, G; Dietlein, M; Borchmann, P; Engert, A INT J RADIAT ONCOL. 2019; 105(1): S1-S1.